# BioLumic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biolumic

- Industry: Agribusiness
- Headquarters: Palmerston North, New Zealand
- Website: www.biolumic.com
- Total disclosed funding: $28M
- Latest round: Series B (Apr 22, 2025)
- Investors on record: 21

## About

Founded in 2013 and based in Palmerston North, New Zealand, BioLumic Limited operates as a developer of ultraviolet lighting treatments for seedlings. Dr Jason Wargent founded the firm. As of 2024, the company is headed by its CEO Steve Sibulkin. In April 2025, BioLumic Limited raised USD 8.3 million in series B funding led by Ki Tua Fund, with participation from Azolla Ventures, iSelect Fund Management, Rabo Investments, AgriZeroNZ, MIG Nominee No 1 Limited, Icehouse Ventures, DYDX Capital, and OurCrowd, along with other unspecified investors. BioLumic's offerings include UV light treatments for seeds and seeling. It uses the biology of UV photomorphogenesis, which triggers biological events in seeds and seedlings this technology supports sustainable farming practices by reducing reliance on traditional chemical inputs.

The company will use the April 2025 funding to accelerate the commercial growth of its xTraits category of seed traits.

## Funding rounds

- Series B, Apr 22, 2025, $8.3M — iSelect Fund Management, MIG Angels, OurCrowd, Rabo Investments, Azolla Ventures, AgriZeroNZ, Ki Tua Fund, DYDX Capital
- Series B, Jun 21, 2022, $14M — Nordwind Capital, New Zealand Growth Capital Partners, Finistere Ventures, ArcView Group, OurCrowd, Rabo Investments, Icehouse Ventures, Booster, Entourage Effect Capital, Flatiron Venture Partners, RIV Capital, Bravos Capital, Virtu Capital Partners, MIG Nominee No 1 Limited
- Series A, May 17, 2019, $1.5M — Rabo Investments, Radicle Growth, RIV Capital
- Series A, Mar 14, 2018, $5M — Finistere Ventures, Rabo Investments, Radicle Growth

## Investors

- Finistere Ventures (https://capitalatlas.ai/funds/finistere-ventures) — Series A, Series B
- Rabo Investments (https://capitalatlas.ai/funds/rabo-investments) — Series A, Series B
- Radicle Growth (https://capitalatlas.ai/funds/radicle-growth) — Series A
- RIV Capital (https://capitalatlas.ai/funds/riv-capital) — Series A, Series B
- Nordwind Capital (https://capitalatlas.ai/funds/nordwind-capital) — Series B
- New Zealand Growth Capital Partners — Series B
- ArcView Group (https://capitalatlas.ai/funds/arcview-group) — Series B
- OurCrowd (https://capitalatlas.ai/funds/ourcrowd) — Series B
- Icehouse Ventures (https://capitalatlas.ai/funds/icehouse-ventures) — Series B
- Booster — Series B
- Entourage Effect Capital (https://capitalatlas.ai/funds/entourage-effect-capital) — Series B
- Flatiron Venture Partners (https://capitalatlas.ai/funds/flatiron-venture-partners) — Series B
- Bravos Capital (https://capitalatlas.ai/funds/bravos-capital) — Series B
- Virtu Capital Partners (https://capitalatlas.ai/funds/virtu-capital-partners) — Series B
- MIG Nominee No 1 Limited — Series B
- iSelect Fund Management (https://capitalatlas.ai/funds/iselect-fund-management) — Series B
- MIG Angels (https://capitalatlas.ai/funds/mig-angels) — Series B
- Azolla Ventures (https://capitalatlas.ai/funds/azolla-ventures) — Series B
- AgriZeroNZ (https://capitalatlas.ai/funds/agrizeronz) — Series B
- Ki Tua Fund (https://capitalatlas.ai/funds/ki-tua-fund) — Series B
- DYDX Capital (https://capitalatlas.ai/funds/dydx-capital) — Series B